Page last updated: 2024-09-05
nutlin 3 and ML-210
nutlin 3 has been researched along with ML-210 in 1 studies
Compound Research Comparison
| Studies (nutlin 3) | Trials (nutlin 3) | Recent Studies (post-2010) (nutlin 3) | Studies (ML-210) | Trials (ML-210) | Recent Studies (post-2010) (ML-210) |
|---|---|---|---|---|---|
| 12 | 0 | 10 | 7 | 0 | 7 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Feng, QS; Han, B; He, G; Liu, SJ; Mao, Q; Peng, C; Wu, F; Zhang, FH; Zhao, Q | 1 |
Other Studies
1 other study(ies) available for nutlin 3 and ML-210
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Molecular Structure; Nitro Compounds; Oxindoles; Phospholipid Hydroperoxide Glutathione Peroxidase; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship | 2021 |